Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alignment Healthcare (ALHC) Cash from Investing Activities (2020 - 2025)

Historic Cash from Investing Activities for Alignment Healthcare (ALHC) over the last 6 years, with Q3 2025 value amounting to $2.3 million.

  • Alignment Healthcare's Cash from Investing Activities rose 10942.59% to $2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$13.7 million, marking a year-over-year decrease of 13114.1%. This contributed to the annual value of $39.2 million for FY2024, which is 12661.29% up from last year.
  • Per Alignment Healthcare's latest filing, its Cash from Investing Activities stood at $2.3 million for Q3 2025, which was up 10942.59% from -$6.7 million recorded in Q2 2025.
  • In the past 5 years, Alignment Healthcare's Cash from Investing Activities ranged from a high of $42.7 million in Q1 2024 and a low of -$110.4 million during Q1 2023
  • Over the past 5 years, Alignment Healthcare's median Cash from Investing Activities value was -$6.1 million (recorded in 2022), while the average stood at -$8.7 million.
  • Its Cash from Investing Activities has fluctuated over the past 5 years, first plummeted by 170231.76% in 2023, then surged by 20288.44% in 2024.
  • Over the past 5 years, Alignment Healthcare's Cash from Investing Activities (Quarter) stood at -$3.0 million in 2021, then plummeted by 174.72% to -$8.1 million in 2022, then soared by 87.44% to -$1.0 million in 2023, then plummeted by 481.53% to -$5.9 million in 2024, then skyrocketed by 139.1% to $2.3 million in 2025.
  • Its last three reported values are $2.3 million in Q3 2025, -$6.7 million for Q2 2025, and -$3.5 million during Q1 2025.